What is the most recent earnings date for MRKR stock?
MARKER THERAPEUTICS INC (MRKR) last reported earnings on 11/13/2025.
MARKER THERAPEUTICS INC (MRKR) Earnings History & Surprises
NASDAQ:MRKR • US57055L2060
Current stock price
1.36 USD
-0.05 (-3.55%)
Last:
MRKR Earnings overview
Past quarterly earnings results for MARKER THERAPEUTICS INC (MRKR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.20
- Revenue Estimate
- 695.64K
Last Reported
Most Recent- Release Date
- Nov 13, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.12
- EPS Surprise
- 73.86%
- Revenue Surprise
- 67.20%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.12 | -0.46 | 73.86% | 53.85% | 1.233M | 737.46K | 67.20% | -35.98% |
| Q2 2025 | -0.29 | -0.42 | 30.66% | -16.00% | 861K | 737.46K | 16.75% | -26.35% |
| Q1 2025 | -0.36 | -0.50 | 28.04% | -33.33% | 349K | 510K | -31.57% | -71.95% |
| Q4 2024 | -0.42 | -0.22 | -87.59% | 54.25% | 2.252M | 4.062M | -44.56% | 113.16% |
| Q3 2024 | -0.26 | -0.40 | 34.64% | 71.68% | 1.926M | 1.02M | 88.82% | 640.77% |
| Q2 2024 | -0.25 | -0.44 | 43.00% | 69.36% | 1.169M | - | 53.82% | |
| Q1 2024 | -0.27 | -0.26 | -5.04% | 66.91% | 1.244M | - | 1.14% | |
| Q4 2023 | -0.92 | - | -91.25% | 1.057M | - | -68.08% | ||
| Q3 2023 | -0.92 | - | -14.75% | 260K | - | -74.00% | ||
| Q2 2023 | -0.82 | - | 25.82% | 760K | - | -3.80% | ||
| Q1 2023 | -0.82 | - | 32.00% | 1.23M | - | 28.13% | ||
| Q4 2022 | -0.48 | -1.02 | 52.94% | 60.00% | 3.31M | - | 166.94% | |
| Q3 2022 | -0.80 | -1.22 | 34.64% | 33.33% | 1M | 272.003K | 267.64% | - |
| Q2 2022 | -1.10 | -1.29 | 14.86% | 15.38% | 790K | 680.003K | 16.18% | - |
| Q1 2022 | -1.20 | -1.36 | 11.76% | 25.00% | 960K | - | - | |
| Q4 2021 | -1.20 | -1.30 | 7.73% | 33.33% | 1.24M | - | - | |
| Q3 2021 | -1.20 | -1.30 | 7.73% | 25.00% | - | - | ||
| Q2 2021 | -1.30 | -1.20 | -8.47% | 7.14% | - | -100.00% | ||
| Q1 2021 | -1.60 | -1.48 | -8.18% | -14.29% | - | - | ||
| Q4 2020 | -1.80 | -1.63 | -10.29% | - | - | - | ||
| Q3 2020 | -1.60 | -1.46 | -9.44% | - | - | - | ||
| Q2 2020 | -1.40 | -1.45 | 3.68% | - | 470K | - | - | |
| Q1 2020 | -1.40 | -1.16 | -20.40% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
11.24%
Max EPS beat (4)
73.86%
Min EPS beat (4)
-87.59%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
1.95%
Max Revenue beat (4)
67.20%
Min Revenue beat (4)
-44.56%
Analysis
In the last 4 quarters, MRKR has beaten EPS estimates in 3 out of 4 releases
MRKR has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, MRKR has beaten the EPS estimates by 11.2% on average.
In the last 4 quarters, MRKR has beaten the revenue estimates by 2.0% on average.
Related analysis
MARKER THERAPEUTICS INC / MRKR Earnings FAQ
Can you provide information on whether MARKER THERAPEUTICS INC beat earnings estimates in the last quarter?
MARKER THERAPEUTICS INC (MRKR) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does MARKER THERAPEUTICS INC (MRKR) beat earnings estimates?
In the last 4 quarters, MARKER THERAPEUTICS INC (MRKR) has beaten EPS estimates in 3 out of 4 releases.